SCHEMBL678538

SCHEMBL678538

S=[C]c1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31375385 0.83 ALDH1A1 (0.43)
SCHEMBL3167431 0.78 ALDH1A1 (0.43)
SCHEMBL2465050 0.74
SCHEMBL11700071 0.74
SCHEMBL1006770 0.74
SCHEMBL444086 0.74
SCHEMBL123243 0.74
SCHEMBL3168192 0.74 ALDH1A1 (0.40)
SCHEMBL7300417 0.74
SCHEMBL60147 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4357466-A FROM A TOSYLATED DERIVATIVE ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1982-11-02 US claimed
JP-56068698-A None JP disclosed
JP-56147797-A None JP disclosed
US-8299035-B2 10a-azalide compound having 4-membered ring structure TAISHO PHARMACEUTUCAL CO., LTD. (JP) 2012-10-30 US disclosed
US-20110269717-A1 NEUROGENESIS BY MODULATING ANGIOTENSIN BRAINCELLS INC. (US) 2011-11-03 US disclosed
US-20110152239-A1 10A-AZALIDE COMPOUND HAVING 4-MEMBERED RING STRUCTURE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-06-23 US disclosed
US-20110046090-A1 MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS BRAINCELLS INC. (US) 2011-02-24 US disclosed
EP-2287173-A1 10A-AZALIDE COMPOUND HAVING 4-MEMBERED RING STRUCTURE Taisho Pharmaceutical Co., Ltd. (JP) 2011-02-23 EP disclosed
WO-2010111136-A2 ALISKIREN MODULATION OF NEUROGENESIS BRAINCELLS, INC. (US) 2010-09-30 WO disclosed
US-7786079-B2 Substituted nonadepsipeptides AICURIS GMBH & CO. KG. (DE) 2010-08-31 US disclosed
US-5621106-A REACTING WITH DIALKYLTIN OXIDE; ACYLATION; ALKYLATION TORONTO RESEARCH CHEMICALS, INC. (CA) 1997-04-15 US disclosed
EP-0733630-A1 NUCLEOSIDE DERIVATIVE NIPPON SHINYAKU COMPANY, LIMITED (JP) 1996-09-25 EP disclosed
US-5466809-A From aminomannose, antitumor agents, castanospermine TORONTO RESEARCH CHEMICALS, INC. (CA) 1995-11-14 US disclosed
US-5432263-A Process for producing peptides with side chains containing imidazolinylamino, tetrahydropyrimidinylamino, or alkylguanidinyl groups ABBOTT LABORATORIES (US) 1995-07-11 US disclosed
EP-0613478-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1994-09-07 EP disclosed
WO-1993009117-A1 IMMUNOSTIMULATING SWAINSONINE ANALOGS TORONTO RESEARCH CHEMICALS INC. (CA) 1993-05-13 WO disclosed
EP-0103445-A2 Process for production of prostaglandins E or F, and novel 7-(thiocarbo-acyloxy) prostaglandins E or F TEIJIN LIMITED (JP) 1984-03-21 EP disclosed
US-4357466-A FROM A TOSYLATED DERIVATIVE ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1982-11-02 US disclosed
JP-S56147797-A NEW PREPARATION OF 3\"-DEOXYDIHYDRO STREPTOMYCIN MICROBIAL CHEM RES FOUND 1981-11-16 JP disclosed
JP-S5668698-A NEW PREPARATION OF 3'-DEOXYKANAMYCIN A MICROBIAL CHEM RES FOUND 1981-06-09 JP disclosed